Biohaven Ltd. (BHVN)

New feature

Thematic Research

Now you can save results to your research library to reference later, and add custom notes to your insights and share.

Add to research

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Company performance
Add to research

Current Price

as of Feb 05, 2025

$39.14

P/E Ratio

N/A

Market Cap

$3.96B

Description
Add to research

Biohaven Ltd. is a global clinical stage biopharmaceutical company, which engages in the discovery, development, and commercialization of therapies for people with neurological and neuropsychiatric diseases. The company was founded on May 2, 2022 and is headquartered in New Haven, CT.

Metrics
Add to research

Overview

  • HQNew Haven, CT
  • SectorHealth Technology
  • IndustryPharmaceuticals: Major
  • TickerBHVN
  • Price$39.14-0.43%

Trading Information

  • Market cap$3.96B
  • Float87.60%
  • Average Daily Volume (1m)900,044
  • Average Daily Volume (3m)962,057
  • EPS-$9.35

Company

  • RevenueN/A
  • Rev growth (1yr)N/A
  • Net income-$160.30M
  • Gross marginN/A
  • EBITDA marginN/A
  • EBITDA-$177.17M
  • EV$4.37B
  • EV/RevenueN/A
  • P/EN/A
  • P/SN/A
  • P/B11.75
Documents
Add to research